| ||||||||||||||
|
|
|||||||||||||
2-Adrenergic Agonist, in Halothane-Anesthetized DogsReceived from the Anesthesiology Service (112A), Veterans Administration Medical Center, Palo Alto, California, and the Department of Anesthesia, Stanford University, Stanford, California.
Abstract
The anesthetic-sparing and hemodynamic effects of the Stereoisomers of the highly selective
2-adrenergic agonist medetomidine were studied in halothane-anesthetized dogs. Male beagles were anesthetized with halothane in oxygen. After a 2-hour equilibration period, halothane MAC and baseline hemodynamic functions were determined. DL-(n = 7), D-(n = 5), or L-medetomidine (n = 5) at 1, 3, and 10 µg/kg was administered via a right atrial port over 15 minutes while each dog was given halothane at the MAC dose for that animal. Twenty minutes after the end of infusion (when the hemodynamic variables were stable), hemodynamic function was reassessed. Halothane MAC was then redetermined. MAC for halothane significantly decreased after DL-medetomidine administration in a dose-dependent fashion to the extent that at the highest dose (10 µg/kg) the halothane MAC was <0.1%. This effect could be mimicked by the D-isomer, whereas the L-isomer was without effect. Neither isomer changed the mean arterial pressure, whereas only the D-isomer significantly decreased heart rate and cardiac output. Medetomidine, the highly selective
2-adrenergic agonist, reduces the MAC for volatile anesthesia by a greater degree than with any other physiologic, pharmacologic, or pathologic intervention thus far reported. The fact that this effect is stereospecific suggests a structure activity relation that can be accounted for by a homogeneous receptor population. The role of medetomidine as a supplemental anesthetic agent appears promising and requires further investigation.
Key Words: SYMPATHETIC NERVOUS SYSTEM, PHARMACOLOGY—medetomidine POTENCY, ANESTHETIC—MAC
This article has been cited by other articles:
![]() |
J. F. A. Hendrickx, E. I. Eger II, J. M. Sonner, and S. L. Shafer Is Synergy the Rule? A Review of Anesthetic Interactions Producing Hypnosis and Immobility Anesth. Analg., August 1, 2008; 107(2): 494 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Hofer, J. Sprung, M. G. Sarr, and D. J. Wedel Anesthesia for a patient with morbid obesity using dexmedetomidine without narcotics: [L'anesthesie chez un patient obese morbide avec la dexmedetomidine sans narcotiques] Can J Anesth, February 1, 2005; 52(2): 176 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Burke and D. J. Henderson Chirality: a blueprint for the future Br. J. Anaesth., April 1, 2002; 88(4): 563 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Horvath, G. Joo, I. Dobos, W. Klimscha, G. Toth, and G. Benedek The Synergistic Antinociceptive Interactions of Endomorphin-1 with Dexmedetomidine and/or S(+)-Ketamine in Rats Anesth. Analg., October 1, 2001; 93(4): 1018 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Inomata, S. Kihara, Y. Yaguchi, Y. Baba, Y. Kohda, and H. Toyooka Reduction in standard MAC and MAC for intubation after clonidine premedication in children Br. J. Anaesth., November 1, 2000; 85(5): 700 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Hall, T. D. Uhrich, J. A. Barney, S. R. Arain, and T. J. Ebert Sedative, Amnestic, and Analgesic Properties of Small-Dose Dexmedetomidine Infusions Anesth. Analg., March 1, 2000; 90(3): 699 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Inomata, Y. Yaguchi, and H. Toyooka The Effects of Clonidine Premedication on Sevoflurane Requirements and Anesthetic Induction Time Anesth. Analg., July 1, 1999; 89(1): 204 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Lakhlani, L. B. MacMillan, T. Z. Guo, B. A. McCool, D. M. Lovinger, M. Maze, and L. E. Limbird Substitution of a mutant alpha 2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo PNAS, September 2, 1997; 94(18): 9950 - 9955. [Abstract] [Full Text] [PDF] |
||||
|